Matthew David Hellmann
Matthew David Hellmann publishes mostly in Oncology, Pulmonary and Respiratory Medicine and Cancer Research, on topics such as Cancer Immunotherapy and Biomarkers, Lung Cancer Treatments and Mutations and Cancer Genomics and Diagnostics.
- World rank
- #236 of 7,710,434 ranked researchers
- Rank in United States
- #123 of 1,627,098
- Works
- 813
- Citations
- 103k
- Citations per work
- 126.1
What does Matthew David Hellmann research?
Matthew David Hellmann's work is mostly in Medicine (68%), Biochemistry, Genetics and Molecular Biology (14%), Immunology and Microbiology (7%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Health Sciences55067.7%
- Medicine55067.7%
- Life Sciences17221.2%
- Everything else9011.1%
- 1Oncology41% of their works
- 2Pulmonary and Respiratory Medicine23% of their works
- 3Cancer Research9% of their works
- 4Immunology7% of their works
- 5Molecular Biology6% of their works
- 6Radiology, Nuclear Medicine and Imaging4% of their works
Research topics
Which keywords describe Matthew David Hellmann's research?
The keywords of their largest research topics: Targeted Therapy, Immune Checkpoint Blockade, PD-1 and PD-L1, Clinical Trials, ALK Inhibitors, EGFR Mutations, Chemotherapy and Immunotherapy.
- Cetuximab
- Dendritic Cells
- CAR T Cells
- Genomic Profiles
- CT Screening
- Mutational Signatures
- Immunotherapy
- EGFR Mutations
- Clinical Trials
- Immune Checkpoint Blockade
- Targeted Therapy
- PD-1 and PD-L1
- ALK Inhibitors
- Chemotherapy
- Cancer Genomics
- Cancer Immunotherapy
- Lung Cancer
- Small-Cell Lung Cancer
- Chimeric Antigen Receptor
- Immunity
- KRAS Mutations
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 21 words, with their numbers
- Targeted Therapy3443 topics
- Immune Checkpoint Blockade2911 topic
- PD-1 and PD-L12911 topic
- Clinical Trials2392 topics
- ALK Inhibitors1731 topic
- EGFR Mutations1731 topic
- Chemotherapy1693 topics
- Immunotherapy1152 topics
- Cancer Genomics1051 topic
- Mutational Signatures1051 topic
- Cancer Immunotherapy942 topics
- CT Screening671 topic
- Lung Cancer671 topic
- Genomic Profiles661 topic
- Small-Cell Lung Cancer661 topic
- CAR T Cells491 topic
- Chimeric Antigen Receptor491 topic
- Dendritic Cells451 topic
- Immunity451 topic
- Cetuximab361 topic
- KRAS Mutations361 topic
Where does Matthew David Hellmann work?
Matthew David Hellmann's main affiliation in the publication record is Memorial Sloan Kettering Cancer Center, United States.
How many publications and citations does Matthew David Hellmann have?
OpenAlex counts 813 works and 102,532 citations for Matthew David Hellmann, an h-index of 118, ranking #236 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Matthew David Hellmann. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.